4.6 Article

Model-driven discovery of synergistic inhibitors against E-coli and S-enterica serovar Typhimurium targeting a novel synthetic lethal pair, aldA and prpC

期刊

FRONTIERS IN MICROBIOLOGY
卷 6, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fmicb.2015.00958

关键词

synthetic lethality; antibiotic development; drug discovery; systems biology; metabolic reconstruction; bacterial metabolism; model-based drug target discovery; pathway gap filling

资金

  1. NIH/NIGMS [GM098105]
  2. [GM057089]
  3. NNF Center for Biosustainability [New Bioactive Compounds] Funding Source: researchfish
  4. Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish

向作者/读者索取更多资源

Mathematical models of biochemical networks form a cornerstone of bacterial systems biology. Inconsistencies between simulation output and experimental data point to gaps in knowledge about the fundamental biology of the organism. One such inconsistency centers on the gene aldA in Escherichia colt: it is essential in a computational model of E. coli metabolism, but experimentally it is not. Here, we reconcile this disparity by providing evidence that aldA and prpC form a synthetic lethal pair, as the double knockout could only be created through complementation with a plasmid-borne copy of aldA. Moreover, virtual and biological screening against the two proteins led to a set of compounds that inhibited the growth of E. colt and Salmonella enterica serovar Typhimurium synergistically at 100-200 mu M individual concentrations. These results highlight the power of metabolic models to drive basic biological discovery and their potential use to discover new combination antibiotics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据